What is the controversy with buspirone? Exploring the Anxiolytic's Debates
•
4 min read
In 2020, approximately 12 million people in the U.S. were prescribed buspirone, an anxiolytic marketed as a non-sedating alternative to benzodiazepines. Despite its widespread use, **what is the controversy with buspirone** that leads to differing opinions among healthcare providers and patients alike? The debate centers on its effectiveness, particularly in certain populations, its perceived lack of efficacy, and a surprising potential for misuse despite its low addiction risk.
